There are currently multiple national recommendations regarding the age at which women should begin receiving mammography screening. In a recent study, researchers used several models to determine which of...
The US Food and Drug Administration has approved a new option for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
In a recent study, researchers evaluated the risk of arterial thromboembolism, defined as myocardial infarction or ischemic stroke, among patients with and without cancer.
In a recent study, researchers sought to determine if there was an association between depth of tumor response and overall and progression-free survival among patients with non-small cell lung cancer who...
In a recent phase II trial, researchers further investigated the potential long-term benefits of aggressive local treatment in patients with unresectable colorectal liver metastases.
In a recent study, researchers compared the safety, efficacy, and tolerability of 2 treatment combinations for patients with non-small cell lung cancer with brain metastases. To see results of the study,...
After results from a recent trial demonstrated its efficacy, the FDA expanded the indication of a cancer drug to include adult patients with chronic graft versus host disease who do not respond to other...
The FDA granted accelerated approval to a new treatment for adolescent and adult patients with mismatch repair deficient and microsatellite instability metastatic colorectal cancer.
Although melanoma is still the deadliest form of skin cancer, squamous cell carcinoma is now much more common and can be fatal, according to a new study.
In a recent study, researchers evaluated the association between renal transplantation and risk of melanoma. Also evaluated were other risk factors for developing melanoma in this patient population.
